Gilead Sciences logo

Director, Epidemiology and Real-World evidence (EpiRWE)-Oncology

Gilead Sciences

Foster City, CA; Parsippany, NJOnsitePosted 1 day ago$205,615 - $292,710/year
Full TimeDirector & AboveResearch & ScientistPharmaceutical
Original posting ↗

Summary

We are seeking a Director, Epidemiology and Real-World Evidence (EpiRWE)- Oncology who will design and deliver RWE required by internal stakeholders and regulators, ensuring timeliness, quality, and utility, as well as advise on methodological approaches including support of payer and provider interactions. Success in this role requires a strong track record in the design and conduct of epidemiologic studies/analyses, direct expertise in use of RWE at different stages of the product development and commercialization processes, and the ability to manage effort and resources in a cross-functional, matrix setting. This is an office based position - located in either Foster City CA or Parsippany, NJ.

Job description

Duties & Responsibilities

  • Serve as the single point of accountability for the development, execution, and communication of the global RWE strategy supporting late-stage clinical development and post-authorization evidence requirements for one or more products in Franchise(s) in Oncology.
  • Employ robust scientific methods and fit-for-purpose data for the timely execution of the RWE strategy, in alignment with the clinical development plan and broader CST/EMT objectives.
  • Generate, within time, budget, and quality standards, real-world evidence including natural history of disease, population characterization, assessment of treatment patterns and unmet need, development of external comparators, benchmarking of clinical outcomes, comparative safety and effectiveness research, and post-authorization studies.
  • Ensure fulfillment of observational study conduct requirements, such as registration, ethical board approval, protocol, SAP, study report development, and disclosure.
  • Communicate effectively about the utility of RWE across the product lifecycle and drive use of study/analysis results to support internal and external decisions.
  • Contribute to the communication of observational research results, including development of pertinent sections of regulatory documents, publications, white papers.
  • Contribute to timely and appropriate development of epidemiological sections of regulatory documents for agencies worldwide (e.g., Risk Management Plan, orphan or breakthrough designations, Pediatric Investigation Plan, query responses, advisory committee briefing documents).
  • Represent the RWE function in internal cross-functional teams and initiatives.
  • Leverage close collaborations with quantitative functions within CDS (e.g., Biostatistics, Bioinformatics), as well as in Clinical Research, Patient Safety, Medical Affairs, and Global Value and Access to anticipate and meet the evidence needs of regulators, payers, providers, and patients.
  • Identify the need for and contribute directly to the development of processes and delivery of training aimed at increasing the efficiency, quality, and impact of functional activities.

Requirements

  • Doctoral degree (e.g. PhD, MD, ScD, PharmD) and/or Master's degree (e.g. MSc, MPH) in Epidemiology or related discipline, such as Outcomes Research, Medicine, Biostatistics from an accredited institution, with a minimum of 8 years (PhD) or 10 years (MS) of relevant experience.
  • Preference for a minimum of six (6) years of that experience to be in the biopharmaceutical industry.
  • Direct experience with different applications of RWE, including in support of early and/or late-stage development clinical development, regulatory approvals, and/or safety commitments.
  • Experience designing and conducting observational research, including protocol, statistical analysis plan, and study report development.
  • Experience with secondary data analysis, including electronic medical record and/or medical claims databases, and with statistical analysis tools, such as SAS and R.
  • A track record of scientific publications demonstrating expertise in observational study design, analysis, and interpretation is preferred.
  • Knowledge of the Oncology therapeutic area.
  • Experience leading studies and projects in a matrix setting.
  • Demonstrated ability to function with autonomy and develop productive cross-functional collaborations.
  • Ability to manage priorities, resources, and performance targets.
  • Well-developed cross-cultural sensitivity.

Requirements

  • Doctoral degree (e.g. PhD, MD, ScD, PharmD) and/or Master's degree (e.g. MSc, MPH) in Epidemiology or related discipline such as Outcomes Research, Medicine, Biostatistics from an accredited institution
  • Minimum of 8 years (PhD) or 10 years (MS) of relevant experience
  • Preference for a minimum of six (6) years of experience in the biopharmaceutical industry
  • Direct experience with different applications of RWE, including support of early and/or late-stage clinical development, regulatory approvals, and/or safety commitments
  • Experience designing and conducting observational research, including protocol, statistical analysis plan, and study report development
  • Experience with secondary data analysis, including electronic medical record and/or medical claims databases
  • Experience with statistical analysis tools such as SAS and R
  • A track record of scientific publications demonstrating expertise in observational study design, analysis, and interpretation is preferred
  • Knowledge of the Oncology therapeutic area
  • Experience leading studies and projects in a matrix setting
  • Demonstrated ability to function with autonomy and develop productive cross-functional collaborations
  • Ability to manage priorities, resources, and performance targets
  • Well-developed cross-cultural sensitivity

Benefits

  • Medical, Dental & Vision
  • Life Insurance
  • Paid Time Off
  • Discretionary Annual Bonus
  • Stock-Based Long-Term Incentives

Company overview

Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.